Literature DB >> 20944860

A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles.

Hoang Ngoc Ai Tran1, Fernanda Sousa, Fabio Moda, Subhra Mandal, Munish Chanana, Chiara Vimercati, Michela Morbin, Silke Krol, Fabrizio Tagliavini, Giuseppe Legname.   

Abstract

Gold nanoparticles coated with oppositely charged polyelectrolytes, such as polyallylamine hydrochloride and polystyrenesulfonate, were examined for potential inhibition of prion protein aggregation and prion (PrPSc) conversion and replication. Different coatings, finishing with a positive or negative layer, were tested, and different numbers of layers were investigated for their ability to interact and reduce the accumulation of PrPSc in scrapie prion infected ScGT1 and ScN2a cells. The particles efficiently hampered the accumulation of PrPSc in ScN2a cells and showed curing effects on ScGT1 cells with a nanoparticle concentration in the picomolar range. Finally, incubation periods of prion-infected mice treated with nanomolar concentrations of gold nanoparticles were significantly longer compared to untreated controls.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944860     DOI: 10.1039/c0nr00551g

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  9 in total

Review 1.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 2.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

3.  Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.

Authors:  P A Broderick; L Wenning; Y-S Li
Journal:  J Neural Transm (Vienna)       Date:  2016-10-28       Impact factor: 3.575

4.  A novel expression system for production of soluble prion proteins in E. coli.

Authors:  Romany N N Abskharon; Stephanie Ramboarina; Hassan El Hassan; Wael Gad; Marcin I Apostol; Gabriele Giachin; Giuseppe Legname; Jan Steyaert; Joris Messens; Sameh H Soror; Alexandre Wohlkonig
Journal:  Microb Cell Fact       Date:  2012-01-10       Impact factor: 5.328

5.  Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process.

Authors:  Negin Javdani; Sayyed Shahryar Rahpeyma; Younes Ghasemi; Jamshid Raheb
Journal:  Int J Nanomedicine       Date:  2019-01-23

Review 6.  The Influence of Size and Chemical Composition of Silver and Gold Nanoparticles on in vivo Toxicity with Potential Applications to Central Nervous System Diseases.

Authors:  Daniela F Báez; Eduardo Gallardo-Toledo; María Paz Oyarzún; Eyleen Araya; Marcelo J Kogan
Journal:  Int J Nanomedicine       Date:  2021-03-15

Review 7.  Nano-Neurotheranostics: Impact of Nanoparticles on Neural Dysfunctions and Strategies to Reduce Toxicity for Improved Efficacy.

Authors:  Chiluka Vinod; Srikanta Jena
Journal:  Front Pharmacol       Date:  2021-03-26       Impact factor: 5.810

Review 8.  Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches.

Authors:  Carolina Velasco-Aguirre; Francisco Morales; Eduardo Gallardo-Toledo; Simon Guerrero; Ernest Giralt; Eyleen Araya; Marcelo J Kogan
Journal:  Int J Nanomedicine       Date:  2015-08-10

9.  Prion protein interaction with soil humic substances: environmental implications.

Authors:  Gabriele Giachin; Joanna Narkiewicz; Denis Scaini; Ai Tran Ngoc; Alja Margon; Paolo Sequi; Liviana Leita; Giuseppe Legname
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.